← Leaderboards
Brian C Miller
Harvard Medical School
$1,157,086
Attributed
$1,157,086
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $286.7K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,157,086 · 1
By mechanism
K08$1,157,086 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Arlene H Sharpe$68,359,602
- Simon Young$4,502,912
- Marcia Haigis$12,366,449
- Dawn E Comstock$175,798
- Nathalie Yr Agar$10,055,254
Others in their field
Other Emerging Leaders on “Advisory Committees”
- Claudia Valmonte · The Emmes Company, Llc$37,865,589
- James Lu · Helix$12,461,593
- Hemali Phatnani · New York University School Of Medicine$12,067,974
- Patrick A Flume · Medical University Of South Carolina$11,656,627
- Sonia Savelli · University Of Washington$11,147,222
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
Advisory CommitteesAnti-Pd-1Anti-Pd1 TherapyAntigen PresentationBiopsyCancer CellCancer TherapyCareer DevelopmentCell KillingCell LineCellsCellular BiologyClinical EfficacyClinical PracticeCombination ImmunotherapyCombined Modality TherapyComputational BiologyDana-Farber Cancer InstituteData SetDevelopment PlansDissectionDoctor Of PhilosophyEducational Process Of InstructingEffector Cell
Grant awards (6)
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations$286,658
K08 · FY2024 · CA · contact PI
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations$286,658
K08 · FY2023 · CA · contact PI
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations$194,590
K08 · FY2022 · CA · contact PI
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations$194,589
K08 · FY2021 · CA · contact PI
Targeting Unique Myeloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations$1
K08 · FY2021 · CA · contact PI
Targeting Unique Myeloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations$194,590
K08 · FY2020 · CA · contact PI